Showing 581 - 600 results of 674 for search '"prevention (medical)"', query time: 0.25s Refine Results
  1. 581
  2. 582
  3. 583
  4. 584

    Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort by Marta Waliszewska-Prosół, Marcin Straburzyński, Ewa K. Czapińska-Ciepiela, Magdalena Nowaczewska, Anna Gryglas-Dworak, Sławomir Budrewicz

    Published 2023-04-01
    “…In the MwoA cohort, 1553 (92.5%) of participants declared the current use of some form of treatment, although only 193 (11.5%) respondents were currently on preventive medications. The most prevalent comorbidities included: chronic rhinitis (37.1%), allergies (35.9%) and low blood pressure (26.9%). …”
    Get full text
    Article
  5. 585

    The Potential Contribution of BRCA Mutations to Early Onset and Familial Breast Cancer in Uzbekistan by Abdulla Abdikhakimov, Mukaddas Tukhtaboeva, Bakhtiyar Adilov, Shahlo Turdikulova

    Published 2016-12-01
    “…To reduce the risk of developing cancer and to increase the likelihood of early detection, carriers of BRCA1 or BRCA2 mutations are offered surveillance programs and effective preventive medical interventions. Identification of founder mutations of BRCA1/2 in high risk communities can have a significant impact on the management of hereditary cancer at the level of the national healthcare systems, making genetic testing more affordable and cost-effective. …”
    Get full text
    Article
  6. 586

    Identification of natural peptides from “PlantPepDB” database as anti-SARS-CoV-2 agents: A protein-protein docking approach by Priyanka Bhandu, Himanshu Verma, Baddipadige Raju, Gera Narendra, Shalki Choudhary, Manmeet Singh, Pankaj Kumar Singh, Om Silakari

    Published 2023-05-01
    “…Still, there's no specific drug or preventive medication to treat SARS-CoV-2. This study was designed to demonstrate the efficacy of some anti-viral peptides obtained from a plant database i.e., PlantPepDB as potential ACE-2-Spike (S) protein complex neutralizers using a structure-based drug designing approach. …”
    Get full text
    Article
  7. 587

    Analysis of medical malpractice liability disputes related to novel antineoplastic drugs and research on risk prevention and control strategies. by Jinyu Luo, Zaoqian Zheng, Rongliang Yu

    Published 2023-01-01
    “…<h4>Objective</h4>To investigate the general characteristics of litigation cases of medical malpractice liability disputes (MMLDs) related to novel antineoplastic drugs (NADs), the drugs involved, as well as the common types of medical errors related to NADs and their damages in the process of diagnosis and treatment, with the aims of improving the level of rational medication use in the clinical application of NADs and actively prevent medical disputes.<h4>Methods</h4>The China Judgments Online was searched for the cause of action using the key word "MMLDs" along with the name of 77 kinds of NADs. …”
    Get full text
    Article
  8. 588

    On the Necessity of Development of the Criteria of Professional Suitability of the Workers with Arterial Hypertension by Grechkivska N.

    Published 2015-03-01
    “…The analysis was provided by 35 medical commissions in Kyiv that carried out preventive medical examinations for people working in hazardous and hazardous working conditions during 2009-2013. …”
    Get full text
    Article
  9. 589

    An Exposure-Based Video Game (Dr. Zoo) to Reduce Needle Phobia in Children Aged 3 to 6 Years: Development and Mixed Methods Pilot Study by Pat Healy, Celine Lu, Jennifer S Silk, Oliver Lindhiem, Reagan Harper, Abhishek Viswanathan, Dmitriy Babichenko

    Published 2023-10-01
    “… BackgroundNeedle phobia, which affects 19% of children aged 4 to 6 years, prevents many children from receiving necessary or preventive medical treatments. Digital interventions have been made to target needle phobia but currently rely on distraction rather than evidence-based exposure. …”
    Get full text
    Article
  10. 590

    Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study by David Prieto-Merino, Pablo Perel, Éimhín Ansbro, Philippa Boulle, Ruth Willis, Sahar Masri, Sola Aoun Bahous, Lucas Molfino

    Published 2023-01-01
    “…Objectives This pre–post implementation study evaluated the introduction of fixed dose combination (FDC) medications for atherosclerotic cardiovascular disease (ASCVD) secondary prevention into routine care in a humanitarian setting.Setting Two Médecins sans Frontières (MSF) primary care clinics serving Syrian refugee and host populations in north Lebanon.Participants Consenting patients ≥18 years with existing ASCVD requiring secondary prevention medication were eligible for study enrolment. …”
    Get full text
    Article
  11. 591

    Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Türkiye Cohort by Aytekin Oğuz, Mustafa Kılıçkap, Sadi Guleç, Yüksel Altuntaş, Kubilay Karşıdağ, Ahmet Temizhan, Özge Telci Çaklılı, Kevser Burcu Tümerdem Çalık, Miraç Vural Keskinler, Sumathy Rangarajan, Salim Yusuf

    Published 2023-07-01
    “…We evaluated risk factors for cardiovascular disease, cardiovascular events, and the use of preventive medications in patients with diabetes mellitus using the Prospective Urban and Rural Epidemiological Türkiye cohort. …”
    Get full text
    Article
  12. 592

    Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache by Heejung Mo, Byung-Kun Kim, Heui-Soo Moon, Soo-Jin Cho

    Published 2022-10-01
    “…Abstract Background Galcanezumab of 300 mg monthly is the FDA approved preventive medication for cluster headache (CH) during the cluster period. …”
    Get full text
    Article
  13. 593

    The Efficacy and Safety of Diyushengbai Tablet on Preventing and Treating Leukopenia Caused by Radiotherapy and Chemotherapy Against Tumor: A Systematic Review and Meta-Analysis by Xiaoqing Xu, Hongmin Li, Xiwen Hu, Juan Liu, Fang Zhao, Kaiyong Xie, Jun Wang

    Published 2022-07-01
    “…The results of meta-analysis showed that for preventive medication purpose, the overall incidence of leukocyte suppression was [RR = 0.74, 95%CI (0.59, 0.92), p = 0.006], and the white blood cell count was [MD = 1.12, 95%CI (0.95, 1.29), p &lt; 0.00001]; while for therapeutic purpose, the incidence of overall leukocyte suppression was [RR = 0.61, 95%CI (0.38, 0.95), p = 0.03], and the white blood cell count was [MD = 1.20, 95%CI (0.77, 1.62), p &lt; 0.00001]. …”
    Get full text
    Article
  14. 594

    Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study by Pablo Irimia, David García-Azorín, Mercedes Núñez, Sílvia Díaz-Cerezo, Pepa García de Polavieja, Tommaso Panni, Aram Sicras-Navarro, Antoni Sicras-Mainar, Antonio Ciudad

    Published 2022-07-01
    “…Methods Retrospective observational study with retrospective cohort design of individuals with migraine treated with oral preventive medication for the first time from 01/01/2016 to 30/06/2018. …”
    Get full text
    Article
  15. 595

    Determining the Causal Effect of Statins on Reducing the Incidence of Venous Thromboembolism after Ankle Fractures by Richard Fischer MS, Nour Nassour MD, Akhbari Bardiya PhD, Christopher W. DiGiovanni MD, Joseph Shwab MD, Hamid Ghaednia PhD, Soheil Ashkani-Esfahani

    Published 2023-12-01
    “…Category: Ankle; Other Introduction/Purpose: It can be challenging to decide when to give preventative medication for venous thromboembolism (VTE). …”
    Get full text
    Article
  16. 596
  17. 597

    A population-based cohort study of coronary heart disease after a myocardial infarction : six-year follow-up by Wright, F

    Published 2006
    “…Most coronary preventive medications were initiated at either hospital discharge or within the first year. …”
    Thesis
  18. 598

    Adoption and non-adoption of a shared electronic summary record in England: a mixed-method case study. by Greenhalgh, T, Stramer, K, Bratan, T, Byrne, E, Russell, J, Potts, H

    Published 2010
    “…There was no direct evidence of improved safety, but findings were consistent with a rare but important positive impact on preventing medication errors. SCRs sometimes contained incomplete or inaccurate data, but clinicians drew judiciously on these data along with other sources. …”
    Journal article
  19. 599

    The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014). by Turner, H, Bettis, A, Chu, B, McFarland, D, Hooper, P, Ottesen, E, Bradley, M

    Published 2016
    “…The economic savings associated with this disease prevention was then analysed in the context of prevented medical expenses incurred by LF clinical patients, potential income loss through lost-labour, and prevented costs to the health system to care for affected individuals. …”
    Journal article
  20. 600